CTOs on the Move

HomeRiver Group

www.homeriver.com

 
Temple Terrace property management at its best. Let HomeRiver Group®s experienced Temple Terrace property managers care for your rental home. If you are looking for a Temple Terrace home for rent search our available rentals quickly and easily.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.homeriver.com
  • 12906, Tampa Oaks Boulevard
    Temple Terrace, FL USA 33637
  • Phone: 888.667.5474

Executives

Name Title Contact Details

Similar Companies

Arcadia Data

Arcadia Data builds the industry only Unified Visual Analytics and BI Platform for big data. We were founded with the singular mission to connect business users to Hadoop. The Arcadia Converged Analytics Platform unifies visual exploration and back-end data analytics in one integrated enterprise platform that runs natively on your Hadoop cluster. We converge the visual, analytics and data layers to provide accelerated access to all of the data stored within Hadoop, and support net-new analytics on granular datasets. Our world-class team from Aster Data, Teradata, 3PAR and IBM has a history of developing stellar products in the big data, analytics, and BI spaces.

Barrs, Chuck

Barrs, Chuck is a Natick, MA-based company in the Software and Internet sector.

E Squared Workshops Inc

E Squared Workshops Inc is a Crofton, MD-based company in the Software and Internet sector.

Progilisys Solutions

Progilisys Solutions is a staffing and recruiting company that specializes in IT consulting, staffing, and executive placement services. They design and deploy technology solutions to meet their customers strategic business requirements.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.